Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise A Critical Review of the Literature in the Decade 2004–2013Reportar como inadecuado




Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise A Critical Review of the Literature in the Decade 2004–2013 - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

1

Department of Molecular Medicine, Biochemistry Unit, University of Pavia, Via Taramelli 3-B, Pavia 27100, Italy

2

Department of Pulmonology, Leiden University Medical Center, Leiden 2333, The Netherlands

3

Department of Biology and Biotechnologies, Biochemistry Unit, University of Pavia, Via Taramelli 3-B, Pavia 27100, Italy

4

Faculty of Science -Parc Valrose-, University of Nice -Sophia Antipolis-, FRE 3472 CNRS, LP2M Nice, France

5

Department of Molecular Medicine, Division of Pneumology, University of Pavia & IRCCS Policlinico San Matteo, Via Taramelli 5, Pavia 27100, Italy





*

Author to whom correspondence should be addressed.



Abstract To improve the knowledge on a variety of severe disorders, research has moved from the analysis of individual proteins to the investigation of all proteins expressed by a tissue-organism. This global proteomic approach could prove very useful: i for investigating the biochemical pathways involved in disease; ii for generating hypotheses; or iii as a tool for the identification of proteins differentially expressed in response to the disease state. Proteomics has not been used yet in the field of respiratory research as extensively as in other fields, only a few reproducible and clinically applicable molecular markers, which can assist in diagnosis, having been currently identified. The continuous advances in both instrumentation and methodology, which enable sensitive and quantitative proteomic analyses in much smaller amounts of biological material than before, will hopefully promote the identification of new candidate biomarkers in this area. The aim of this report is to critically review the application over the decade 2004–2013 of very sophisticated technologies to the study of respiratory disorders. The observed changes in protein expression profiles from tissues-fluids of patients affected by pulmonary disorders opens the route for the identification of novel pathological mediators of these disorders. View Full-Text

Keywords: respiratory diseases; nano-LC-MS-MS; proteomics respiratory diseases; nano-LC-MS-MS; proteomics





Autor: Simona Viglio 1, Jan Stolk 2, Paolo Iadarola 3,* , Serena Giuliano 1,4, Maurizio Luisetti 5, Roberta Salvini 1, Marco Fumagalli 3 and Anna Bardoni 1

Fuente: http://mdpi.com/



DESCARGAR PDF




Documentos relacionados